SCHEMBL13065612

SCHEMBL13065612

CNc1ccc2nc3c(C(=O)O)c(-c4ccc(C#N)cc4)c(=O)c(OC)c-3oc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 2/20 0.36
CNR2 P34972 2/20 0.36
CYP3A4 P08684 1/20 0.36
MAPT P10636 1/20 0.36
ALOX15 P16050 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CEPT1 Q9Y6K0 1/20 0.36
CYP19A1 P11511 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
APP P05067 1/20 0.34
DHODH Q02127 1/20 0.34
CETP P11597 3/20 0.33
TARBP2 Q15633 1/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
IMPDH2 P12268 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13065587 0.89 CASP3 (0.41) CYP3A4MAPTSMN1; SMN2RXFP1DHODH
SCHEMBL13065590 0.87 MAPT (0.38) MAPTSMN1; SMN2RXFP1DHODHTARBP2
SCHEMBL13065745 0.86 ABCG2 (0.39) CNR1CNR2CYP3A4MAPTALOX15
SCHEMBL13065608 0.84 MEN1 (0.39) CNR1CNR2CYP3A4MAPTALOX15
SCHEMBL13065609 0.83 GPR35 (0.41) CYP3A4MAPTSMN1; SMN2DHODHMEN1
SCHEMBL16784715 0.80 TP53 (0.42) CYP3A4MAPTCASP1CASP7DHODH
SCHEMBL13065611 0.77 GPR119 (0.39) CNR1MAPTSMN1; SMN2RXFP1DHODH
SCHEMBL13065589 0.77 DHODH (0.40) MAPTAPPDHODHMEN1NPC1
SCHEMBL13065744 0.75 ABCG2 (0.48) CYP3A4MAPTSMN1; SMN2DHODHMEN1
SCHEMBL16784718 0.75 MAPT (0.41) CYP3A4MAPTDHODHMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9052324-B2 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. (US) 2015-06-09 US disclosed
US-20120322717-A9 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. 2012-12-20 US disclosed
US-20100298200-A1 Compounds and assays for controlling Wnt activity LIU DAKAI 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322717-A9 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 CNR1 3893/4885CNR2 4239/4885CYP3A4 4203/4885
US-20100298200-A1 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 CNR1 3893/4885CNR2 4239/4885CYP3A4 4203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.